Electronic Prescriptions for Controlled Substances (EPCS)

Electronic Prescriptions for Controlled Substances (EPCS) is a Drug Enforcement Administration (DEA)-regulated process that allows authorized prescribers to electronically create, sign, and transmit prescriptions for controlled substances, such as opioids and stimulants, directly to pharmacies. By replacing paper prescriptions with secure electronic workflows, EPCS streamlines the prescribing process while enhancing patient safety and reducing the risk of prescription fraud and errors.

One of the primary benefits of EPCS is improved patient safety. By digitizing the prescription process, EPCS reduces the likelihood of errors that can occur with handwritten prescriptions, such as illegible handwriting or misinterpretation of dosages. Additionally, EPCS systems often include built-in checks and balances, such as drug interaction alerts and dosage limits, which help healthcare providers make informed decisions and avoid potential harm to patients. This can lead to better patient outcomes and a more efficient healthcare system.

DEA regulations require prescribers who use EPCS to undergo identity proofing before being granted electronic prescribing privileges. When signing a controlled-substance prescription, prescribers must also use two-factor authentication (2FA), combining credentials from two distinct authentication factor categories, such as something they know (a password), something they have (a hard token, cryptographic key, or approved authentication device), or something they are (biometric verification). This authentication is tied directly to the legal signing event, helping verify that the authorized prescriber personally approved the prescription.

EPCS also enhances security and compliance through logical access controls that restrict controlled-substance prescribing privileges to authorized prescribers. Healthcare organizations must establish and maintain these permissions over time, ensuring access is updated when clinicians join or leave the organization, lose prescribing authority, or have credentials that are compromised or otherwise require revocation. Because controlled substances are highly regulated due to their potential for abuse and diversion, EPCS can only be used when both the prescriber’s electronic prescribing application and the pharmacy’s prescription processing application meet DEA requirements for the electronic prescribing of controlled substances, including identity proofing, two-factor authentication, logical access controls, audit capabilities, record retention, and other security safeguards.

Furthermore, DEA regulations require EPCS applications to maintain detailed audit trails and electronic records for at least two years. EPCS software must undergo third-party certification or audit processes to verify compliance with DEA requirements. Organizations are also required to review audit information and perform regular internal audits to identify unauthorized access attempts, inappropriate privilege assignments, or other security-related events. Suspected security incidents, unauthorized access attempts, and credential compromises must also be investigated and addressed in accordance with organizational policies and regulatory requirements.

Another significant advantage of EPCS is the convenience it offers both healthcare providers and patients. Providers can write and send prescriptions from anywhere, at any time, as long as they have internet access. This can be particularly beneficial in rural or remote areas by reducing administrative burdens on healthcare organizations with resource constraints, and helping patients receive prescriptions more efficiently. Patients, on the other hand, can have their prescriptions filled more quickly and efficiently, reducing wait times and improving the overall patient experience. EPCS also facilitates the management of chronic conditions, as providers can easily renew prescriptions and monitor patient adherence.